Abstract
Introduction
The aim of this prospective study was to assess the results of a standard low-calorie dietary intervention (7.5 MJ/day) on body weight (BW) and the metabolic profile of obese patients with type 2 diabetes mellitus (T2DM) on intensive insulin therapy (IIT: 4 insulin injections/day) versus conventional insulin therapy (CIT: 2/3 insulin injections/day).
Methods
A total of 60 patients (n = 60, 23 males and 37 postmenopausal females) were recruited and categorized into two groups according to the scheme of insulin treatment. Thirty were on IIT (13 males and 17 females) and an equal number on CIT (10 males and 20 females). BW, body mass index (BMI), HbA1c, and metabolic parameters were compared at 6 and 12 months after baseline.
Results
Significant reductions were observed in the BW, BMI, HbA1c (p ≤ 0.001 for all) and cholesterol (p ≤ 0.05) at 6 months post-intervention. At 1 year, median BW reduction was 4.5 kg (3.3, 5.8) for patients on IIT and 4.8 kg (3.6, 7.0) for those on CIT. The 12-month dietary intervention increased prevalence of normoglycemia in the IIT group and reduced the prevalence of obesity prevalence among the CIT participants (all p < 0.001). CIT patients with BW reduction ≥5.0% demonstrated 11-fold greater chances of being normoglycemic (odds ratio 11.3, 95% CI 1.1–110.5). BW reduction ≥7.0% was associated with CIT, being overweight, and having normal HDLc, LDLc, and cholesterol levels. A reduction in BW between 5.0% and 6.9% was associated with IIT, normoglycemia, and obesity.
Conclusion
A 12-month 1800-kcal dietary intervention achieved significant BW and HbA1c reductions irrespectively of insulin regimen. CIT was associated with BW reduction greater than 8.0%, whereas IIT was associated with higher rates of normoglycemia.
Similar content being viewed by others
References
Galli-Tsinopoulou A, Grammatikopoulou MG, Stylianou C, Emmanouilidou E, Kokka P. Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese. J Endocrinol Invest. 2010;33:549–53.
Blonde L. Benefits and risks for intensive glycemic control in patients with diabetes mellitus. Am J Med Sci. 2012;343:17–20.
Percik R, Stumvoll M. Obesity and cancer. Exp Clin Endocrinol Diabetes. 2009;117:563–6.
Rorive M, Letiexhe MR, Scheen AJ, Ziegler O. Obesity and type 2 diabetes. Rev Med Liege. 2005;60:374–82.
Baker ST, Jerums G, Prendergast LA, Panagiotopoulos S, Strauss BJ, Proietto J. Less fat reduction per unit weight loss in type 2 diabetic compared with nondiabetic obese individuals completing a very-low-calorie diet program. Metabolism. 2012;61:873–82.
Pataky Z, Bobbioni-Harsch E, Golay A. Obesity: a complex growing challenge. Exp Clin Endocrinol Diabetes. 2010;118:427–33.
Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(Suppl 1):S120–43.
Veves A, Baltzis D, Eleftheriadou I. Diabetes treatment: recent developments. Adv Ther. 2013;30:1031–2.
Damon S, Schatzer M, Hofler J, Tomasec G, Hoppichler F. Nutrition and diabetes mellitus: an overview of the current evidence. Wien Med Wochenschr. 2011;161:282–8.
Mangou A, Grammatikopoulou MG, Mirkopoulou D, Sailer N, Kotzamanidis C, Tsigga M. Associations between diet quality, health status and diabetic complications in patients with type 2 diabetes and comorbid obesity. Endocrinol Nutr. 2012;59:109–16.
Franz MJ, Powers MA, Leontos C, Holzmeister LA, Kulkarni K, Monk A, Wedel N, Gradwell E. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc. 2010;110:1852–89.
Sakamoto M, Inoue G, Tsuyusaki K, Usui K, Watanabe M, Irie J, Atsuda K, Yamada S. Comparison of oxidative stress markers in type 2 diabetes: basal bolus therapy versus twice daily premixed insulin analogs. Intern Med. 2010;49:355–9.
Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH, Group EPCS. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352:341–50.
Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373:1765–72.
Group AC, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.
Fritsche A, Larbig M, Owens D, Haring HU, Group Gs. Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study. Diabetes Obes Metab. 2010;12:115–23.
Swinnen SG, Hoekstra JB, DeVries JH. Insulin therapy for type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S253–9.
Brownell KD. Dieting readiness. Weight Con Dig. 1990;1:5–10.
Institute of Medicine. Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. In: Thomas PR, editor. Weighing the Options: Criteria for Evaluating Weight-Management Programs. Washington; 1995
Nielsen JV, Jonsson E, Nilsson AK. Lasting improvement of hyperglycaemia and bodyweight: low-carbohydrate diet in type 2 diabetes–a brief report. Ups J Med Sci. 2005;110:69–73.
Connolly J, Romano T, Patruno M. Selections from current literature: effects of dieting and exercise on resting metabolic rate and implications for weight management. Fam Pract. 1999;16:196–201.
Daly A, Franz M, Holzmeister LA, Kulkarni K, O'Connell B, Wheeler M. New diabetes nutrition resources. J Am Diet Assoc. 2003;103:832–4.
Institute of Medicine (US). Dietary reference intakes: the essential guide to nutrient requirements. Washington DC: National Academies Press; 2006.
American Diabetes Association. Nutrition recommendations and interventions for diabetes. Diabetes Care. 2008;31:S61–78.
Dyson PA, Kelly T, Deakin T, Duncan A, Frost G, Harrison Z, Khatri D, Kunka D, McArdle P, Mellor D, Oliver L, Worth J, Diabetes UKNWG. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med. 2011;28:1282–8.
World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation, vol. 894. World Health Organ Tech Rep SerGeneva. Switzerland: World Health Organisation; 2000.
Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care. 1993;16:1187–9.
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469-80.
American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):S14–80.
Tsakiraki M, Grammatikopoulou MG, Stylianou C, Tsigga M. Nutrition transition and health status of Cretan women: evidence from two generations. Public Health Nutr. 2011;14:793–800.
Sourial N, Wolfson C, Zhu B, Quail J, Fletcher J, Karunananthan S, Bandeen-Roche K, Beland F, Bergman H. Correspondence analysis is a useful tool to uncover the relationships among categorical variables. J Clin Epidemiol. 2010;63:638–46.
Look ARG, Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30:1374–83.
Colagiuri S. Diabesity: therapeutic options. Diabetes Obes Metab. 2010;12:463–73.
Fritsche A, Haring H. At last, a weight neutral insulin? Int J Obes Relat Metab Disord. 2004;28 Suppl 2:S41–6.
Bohn B, Scheuing N, Jehle PM, Laubner K, Born B, Merger S, Hummel M, Krakow D, Voll A, Zimmermann A, Zimny S, Holl RW, Dpv, initiatives APV, the German BCNDm and Obesity. Are insulin analogues detemir or glulisine used preferentially in overweight/obese subjects? A German multicentre analysis of 38560 type 2 diabetic patients from the DPV registry. Exp Clin Endocrinol Diabetes. 2014;122:602–7.
The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998;41:416–23.
Shan L, Hao PP, Chen YG. Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis. J Trauma. 2011;71:1460–4.
Valensi P, Shaban J, Benroubi M, Kawamori R, Borzi V, Shah S, Wenying Y, Prusty V, Hansen JB, Gumprecht J, Panel ISE. Predictors of achieving HbA(1c) <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study. Curr Med Res Opin. 2013;29:601–9.
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32:187–92.
Pontiroli AE, Miele L, Morabito A. Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis. Diabetes Obes Metab. 2011;13:1008–19.
Deakin T. The diabetes pandemic: is structured education the solution or an unnecessary expense? Pract Diabetes. 2011;28:1–7.
Unger J. Uncovering undetected hypoglycemic events. Diabetes Metab Syndr Obes. 2012;5:57–74.
van Dieren S, Czernichow S, Chalmers J, Kengne AP, de Galan BE, Poulter N, Woodward M, Beulens JW, Grobbee DE, van der Schouw YT, Zoungas S. Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial. Diabetes Obes Metab. 2012;14:464–9.
Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovic L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F. American association of clinical endocrinologists and american college of endocrinology—clinical practice guidelines for developing a diabetes mellitus comprehensive care plan—2015. Endocr Pract. 2015;21(Suppl 1):1–87.
Brown AF, Mangione CM, Saliba D, Sarkisian CA, California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with D. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51:S265–80.
Miller CK, Edwards L, Kissling G, Sanville L. Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial. Prev Med. 2002;34:252–9.
Papanas N, Katsiki N, Putz Z, Mikhailidis DP. Diabetes, obesity and vascular disease–an update. Curr Pharm Des. 2013;19:4900–3.
Papanas N, Steiropoulos P, Nena E, Tzouvelekis A, Skarlatos A, Konsta M, Vasdekis V, Maltezos E, Bouros D. Predictors of obstructive sleep apnea in males with metabolic syndrome. Vasc Health Risk Manag. 2010;6:281–6.
Fabricatore AN, Wadden TA, Ebbeling CB, Thomas JG, Stallings VA, Schwartz S, Ludwig DS. Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: a randomized controlled trial. Diabetes Res Clin Pract. 2011;92:37–45.
Rw N. Cholesterol lowering in type 2 diabetes: what is the optimum approach? Clin Diabetes. 2008;26:8–13.
Papazoglou N, Manes C, Chatzimitrofanous P, Papadeli E, Tzounas K, Scaragas G, Kontogiannis I, Alexiades D. Epidemiology of diabetes mellitus in the elderly in northern Greece: a population study. Diabet Med. 1995;12:397–400.
Symeonidis G, Papanas N, Mavridis G, Maltezos E. Evidence that patients at diagnosis of type 2 diabetes mellitus in Northern Greece are increasingly younger and more obese during the last years. Acta Diabetol. 2003;40:1–2.
Papanas N, Maltezos E. Antidiabetic treatment: though lovers be lost, love shall not. World J Diabetes. 2012;3:158–60.
Acknowledgments
No funding or sponsorship was received for this study or publication of this article. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published.
Disclosures
Dimitrios Baltzis, Maria G. Grammatikopoulou, Nikolaos Papanas, Christina-Maria Trakatelli, Evangelia Kintiraki, Maria N. Hassapidou, and Christos Manes declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Compliance with Ethics Guidelines
The institutional ethics committee of the Papageorgiou General Hospital approved the study and patients gave their informed consent prior to participation.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Baltzis, D., Grammatikopoulou, M.G., Papanas, N. et al. Obese Patients with Type 2 Diabetes on Conventional Versus Intensive Insulin Therapy: Efficacy of Low-Calorie Dietary Intervention. Adv Ther 33, 447–459 (2016). https://doi.org/10.1007/s12325-016-0300-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-016-0300-2